| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $42.7M | -60.5% |
| R&D Expense | $182.8M | +14.5% |
| SG&A Expense | $75.3M | +27.6% |
| Operating Income | -$215.4M | -95.1% |
| Pre-tax Income | -$204.4M | -110.7% |
| Income Tax | $0 | — |
| Net Income | -$204.4M | -110.7% |
| EPS (Basic) | -$1.21 | -72.9% |
| EPS (Diluted) | -$1.21 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $602.1M | +99.3% |
| Accounts Receivable | $1.3M | -10.3% |
| Current Assets | $614.8M | +91.9% |
| Total Assets | $638.5M | +81.3% |
| Current Liabilities | $95.1M | -14.3% |
| Total Liabilities | $112.3M | -16.7% |
| Stockholders' Equity | $518.4M | +147.4% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$187.5M | -24.1% |
| Capital Expenditures | $718K | -23.5% |
| Investing Cash Flow | -$718K | +23.5% |
| Financing Cash Flow | $488.2M | +92.3% |
| Free Cash Flow | -$188.2M | -23.9% |
| -72.9% |